News Celltrion Pharm, Inc.

Equities

A068760

KR7068760008

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-05-06 pm EDT			5-day change	1st Jan Change
99,200 ^KRW	+3.77%		+3.23%	+7.59%

Jan. 16	Celltrion Holdings Actively Pursuing Nasdaq Listing	MT
Jan. 02	Celltrion's Shares Climb After Merger With Affiliate	DJ

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Celltrion Holdings Actively Pursuing Nasdaq Listing	Jan. 16	MT
Celltrion's Shares Climb After Merger With Affiliate	Jan. 02	DJ
S.Korean shares end slightly higher as chipmakers advance; US CPI in focus	Dec. 11	RE
South Korean Shares Decline on Concerns over US Fed Rate Hike, China Economic Turmoil	23-08-18	MT
Celltrion Discloses Merger Plans with Celltrion HealthCare; Celltrion Shares Jump 5%	23-08-17	MT
Exclusive-Thermo Fisher, Celltrion vie for Baxter's biopharma unit -sources	23-03-20	RE
South Korean Stocks Rise on Gains by Batterymakers; Samsung SDI Stock Rises 2%	23-03-07	MT
Celltrion Group Creator Expected to Resume Leadership Role	23-03-07	MT
Fosun Pharma, Other Chinese Drugmakers Rise After Deal to Make Merck's Covid-19 Pill	22-01-20	DJ
Celltrion : South Korea approves Celltrion's COVID-19 treatment for use	21-09-17	RE
Samsung Electronics : S.Korea shares dip as surging global coronavirus cases dent sentiment	20-10-26	RE
Celltrion : South Korea pharma Celltrion's COVID test gets U.S. emergency use authorisation	20-10-26	RE
Celltrion Pharm : S.Korea pharma Celltrion's COVID test gets U.S. emergency use authorisation	20-10-25	RE
Samsung Electronics : S.Korea shares jump most in two weeks on falling virus cases, upbeat China data	20-09-28	RE
Celltrion : South Korea's Celltrion to merge with affiliates to set up holding company structure	20-09-25	RE
Celltrion Pharm, Inc.(KOSDAQ:A068760) added to FTSE All-World Index	20-09-21	CI
Celltrion Pharm Inc. Reports Earnings Results for the Year Ended December 31, 2017	18-04-01	CI
Celltrion Pharm Inc. Reports Earnings Results for the Year Ended December 31, 2016	17-04-10	CI
Teva Pharmaceutical May Buy Celltrion	16-10-17	CI
Celltrion Pharm Inc. Reports Earnings Results for the Quarter and Period Ended June 30, 2016	16-08-11	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Celltrion Pharm, Inc.

Equities

A068760

KR7068760008

Summary

Filters